Loperamide
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Loperamide
Description :
Loperamide (ADL 2-1294) is a selective μ opioid receptor agonist with Kis of 3, 48 and 1156 nM against μ, δ and κ opioid receptor, respectively. Loperamide can be used as an antidiarrheal agent[1].CAS Number :
[53179-11-6]Product Name Alternative :
ADL 2-1294UNSPSC :
12352005Hazard Statement :
H315, H319, H320Target :
Opioid ReceptorType :
Reference compoundRelated Pathways :
GPCR/G Protein; Neuronal SignalingApplications :
COVID-19-immunoregulationField of Research :
Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/loperamide.htmlPurity :
99.85Solubility :
DMSO : 100 mg/mL (ultrasonic)Smiles :
O=C(C(C1=CC=CC=C1)(CCN2CCC(C3=CC=C(C=C3)Cl)(CC2)O)C4=CC=CC=C4)N(C)CMolecular Formula :
C29H33ClN2O2Molecular Weight :
477.04Precautions :
H315, H319, H320References & Citations :
[1]DeHaven-Hudkins DL, et al. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J Pharmacol Exp Ther. 1999 Apr;289 (1) :494-502.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
LaunchedCitation 01 :
Curr Med Sci. 2025 Aug 29.|Nature. 2025 Dec;648 (8094) :755-763.|Oncol Rep. 2025 Oct;54 (4) :133.|Phytomedicine. 2025 Oct 16:148:157417.|Cell Rep Methods. 2023 Oct 23;3 (10) :100599.|Dig Dis Sci. 2025 Nov 15.|eFood. 2025 Jul 14.|Food Qual Saf. 2024 Sep 10.|J Appl Microbiol. 2023 Aug 1;134 (8) :lxad153.|J Transl Med. 2021 Jul 23;19 (1) :317.|Viruses. 2021 Jun 28;13 (7) :1255.

